News Hikma Pharmaceuticals PLC

Equities

HIK

GB00B0LCW083

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:26 2025-12-16 am EST			5-day change	1st Jan Change
1,507.00 ^GBX	+0.27%		-2.77%	-24.39%

Dec. 15	FTSE 100 makes headway ahead of likely BoE cut	AN
Dec. 15	London Shares Start Week Higher Ahead of Inflation Data, Monetary Policy Move	MT

FTSE 100 makes headway ahead of likely BoE cut	Dec. 15	AN
London Shares Start Week Higher Ahead of Inflation Data, Monetary Policy Move	Dec. 15	MT
Global markets live: iRobot, Cencora, Franklin Resources, Sanofi, Enel…	Dec. 15
Hikma Pharmaceuticals : Inspiring women of Hikma - Meet Cristina Cagnazzi, Finance Director, Hikma Italy	Dec. 15	PU
Hikma Pharmaceuticals plc Announces Board Changes, Effective December 15, 2025	Dec. 15	CI
Hikma Pharmaceuticals PLC Announces Riad Mishlawi Step Down as Chief Executive Officer	Dec. 15	CI
FTSE rises as miners lift stocks	Dec. 15	AN
Stocks up ahead of busy week for central banks	Dec. 15	AN
UK's Hikma CEO steps down, chairman takes helm until successor appointed	Dec. 15	RE
Hikma Pharmaceuticals CEO replaced by former CEO after guidance cut	Dec. 15	AN
Hikma Pharmaceuticals CEO Steps Down; Executive Chairman Named Successor	Dec. 15	MT
Hikma CEO exits; DBAY to vote against TT deal	Dec. 15	AN
Hikma CEO Riad Mishlawi steps down	Dec. 15	RE
Hikma's CEO Riad Mishlawi steps down	Dec. 15	RE
UK Stocks-Factors to watch on December 15	Dec. 15	RE
Hikma Pharmaceuticals PLC Launches Tyzavan? (vancomycin Injection, USP) in the US	Dec. 08	CI
European Injectables growth: a Q&A with Nassim Rahmani, Associate VP, Commercial Europe & Canada	Dec. 08	PU
Hikma launches Tyzavan in the US	Dec. 08	RE
Hikma Pharmaceuticals : launches TYZAVAN™ (vancomycin injection, USP) in the US	Dec. 08	PU
Hikma Pharmaceuticals : Jefferies London Healthcare Conference Transcript	Nov. 27	PU
Stocks rise, pound firms after "tolerable" budget	Nov. 26	AN
Hikma Pharmaceuticals : Inspiring women of Hikma - Meet Susana Pereira Sr. Director Quality Systems & Validation – EU & MENA Injectables	Nov. 24	PU
Hikma Pharmaceuticals : celebrates 20 years on the London Stock Exchange	Nov. 20	PU
Hikma Pharmaceuticals, DGI Group Enter Licensing Deal for Skin Tag Removal Device	Nov. 20	MT
Strategic Priorities in Hikma Pharmaceuticals R&D: Q&A with Hafrun Fridriksdottir, EVP, Rx and R&D	Nov. 19	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Hikma Pharmaceuticals trims medium-term margins but keeps 2030 growth ambitions

November 07, 2025 at 08:40 am EST